GPX4 and renal cell carcinoma: In these patients, the positive expression rates of SLC7A11 and GPX4 in RCC tissues were 62.4% (78/125) and 57.6% (72/125), respectively and the positive rates in normal renal tissues were 29.6% (37/125) and 26.4% (33/125), respectively.